Correlation Between West Pharmaceutical and Predictive Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both West Pharmaceutical and Predictive Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining West Pharmaceutical and Predictive Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between West Pharmaceutical Services and Predictive Oncology, you can compare the effects of market volatilities on West Pharmaceutical and Predictive Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in West Pharmaceutical with a short position of Predictive Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of West Pharmaceutical and Predictive Oncology.

Diversification Opportunities for West Pharmaceutical and Predictive Oncology

0.25
  Correlation Coefficient

Modest diversification

The 3 months correlation between West and Predictive is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding West Pharmaceutical Services and Predictive Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Predictive Oncology and West Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on West Pharmaceutical Services are associated (or correlated) with Predictive Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Predictive Oncology has no effect on the direction of West Pharmaceutical i.e., West Pharmaceutical and Predictive Oncology go up and down completely randomly.

Pair Corralation between West Pharmaceutical and Predictive Oncology

Considering the 90-day investment horizon West Pharmaceutical Services is expected to generate 0.48 times more return on investment than Predictive Oncology. However, West Pharmaceutical Services is 2.07 times less risky than Predictive Oncology. It trades about 0.05 of its potential returns per unit of risk. Predictive Oncology is currently generating about 0.0 per unit of risk. If you would invest  30,452  in West Pharmaceutical Services on September 4, 2024 and sell it today you would earn a total of  1,813  from holding West Pharmaceutical Services or generate 5.95% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

West Pharmaceutical Services  vs.  Predictive Oncology

 Performance 
       Timeline  
West Pharmaceutical 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in West Pharmaceutical Services are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, West Pharmaceutical may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Predictive Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Predictive Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Predictive Oncology is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.

West Pharmaceutical and Predictive Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with West Pharmaceutical and Predictive Oncology

The main advantage of trading using opposite West Pharmaceutical and Predictive Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if West Pharmaceutical position performs unexpectedly, Predictive Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Predictive Oncology will offset losses from the drop in Predictive Oncology's long position.
The idea behind West Pharmaceutical Services and Predictive Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm